Also trades as: STSS (NASDAQ) · $vol 1M
STSSW NASDAQ
Sharps Technology, Inc.
1W: -1.8%
1M: +28.5%
3M: +67.2%
YTD: +23.6%
1Y: +158.7%
3Y: -84.2%
$0.04
+0.00 (+14.12%)
Weekly Expected Move ±26.5%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.0M
52W Range0.0331-0.07
Volume4,779
Avg Volume120,751
Beta2.02
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOPaul Kruger Danner
Employees55
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2022-04-14
Websitesharpstechnology.com
105 Maxess Road
Melville, NY 11747
US
Melville, NY 11747
US
631-574-4436
About Sharps Technology, Inc.
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
Latest News
Sharps Technology Adopts Limited Duration Stockholder Rights Plan
Sharps Technology (NASDAQ:STSS) Stock Price Down 4.8% – Time to Sell?
Sharps Technology Reports 2025 Year-End Results and Highlights Continued Execution of Solana Treasury Strategy
Sharps Technology Reports 2025 Year-End Results and Highlights Continued Execution of Solana Treasury Strategy
Sharps Technology, Inc. (NASDAQ:STSSW) Sees Large Drop in Short Interest
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Saba Capital Managem | S-Sale | 12,182 | $2.37 | 2026-01-16 |
| Saba Capital Managem | 0 | — | 2026-01-09 | |
| FalconX Holdings Ltd | 0 | — | 2025-10-14 | |
| FalconX Holdings Ltd | 0 | — | 2025-10-14 | |
| Zhang Yuwen | 0 | — | 2025-08-23 |